Clinical trial
Insulin Resistance in Non-alcoholic Fatty Liver Disease
NCT00252499 · US Department of Veterans Affairs, U.S. Fed · Terminated
Key facts
| NCT number | NCT00252499 |
|---|---|
| Title | Insulin Resistance in Non-alcoholic Fatty Liver Disease |
| Official title | Insulin Resistance in Non-alcoholic Fatty Liver Disease |
| Lead sponsor | US Department of Veterans Affairs, U.S. Fed |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Fatty Liver, Insulin Resistance |
| Intervention type | Drug |
| Interventions | rosiglitazone, fenofibrate, placebo for rosiglitazone, placebo for fenofibrate |
| Enrollment | 13 |
| Start date | Oct 1, 2005 |
| Primary completion | Aug 1, 2010 |
| Completion | Aug 1, 2010 |
| First posted | Nov 11, 2005 |
| Last update posted | Aug 20, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: